H1N1 shots from one year onwards
In an effort to immunise more and more people with the HINI influenza vaccine, the Ministry of Health has decided to give the vaccine shots to children from one year old and above.
In an effort to immunise more and more people with the HINI influenza vaccine, the Ministry of Health has decided to give the vaccine shots to children from one year old and above.
Indian pharmaceutical companies welcome in China for meeting their growing domestic demands.
Global Allergy and Asthma European Network (GA2LEN) and the European Academy of Allergy and Clinical Immunology (EAACI) have come up with a finding that that the older generation of HI-antihistamines that are used as allergy medicines may be dangerous to people’s health.
A simple blood test may soon be helpful in predicting rheumatoid arthritis even before symptoms arise according to researchers.
The FDA has approved the drug, Ampyra (generic name dalfampridine, formerly known as fampridine), which is the first Multiple Sclerosis therapy that is taken orally and the first of its kind to receive FDA approval.
Bangalore based biotechnology major Biocon has recorded a profit of 81 crores this quarter.
Through its local organizations in countries throughout the region, Novartis is providing the equivalent of over USD 2.5 million in immediate emergency aid for victims of the recent earthquake in Haiti.
A virtual 3D liver is being used by surgeons to practise keyhole surgery before they perform operations on patients.
TCG Lifesciences has announced a strategic collaboration with ENDO Pharmaceuticals to discover novel small molecule drug candidates for the treatment of pain.
The government has launched a first-of-its-kind bivalent oral polio vaccine (BOPV), a single drop to protect against two deadly strains of polio presently existing in the country
GlaxoSmithKline is likely to get 1 billion pound revenue boost in 2010, as governments stockpile swine flu medicines designed to combat a possible pandemic.
Adults in the US are more likely to be given a combination of two or more drugs today than ten years ago, according to a new report.
Novo Nordisk and the Swedish university consortium Combine have announced a research collaboration in the field of autoimmune diseases.